Earnings Feed
Start Free
Home/Filings/4/0001209191-11-022982
4//SEC Filing

CLINICAL DATA INC 4

Accession 0001209191-11-022982

CIK 0000716646operating
View on SEC.govCompany Profile

Filed

Apr 14, 8:00 PM ET

Accepted

Apr 15, 10:54 AM ET

Size

25.5 KB

Accession

0001209191-11-022982

Insider Transaction Report

Form 4
Period: 2011-04-13
CLINICAL DATA INCCLDA
BELBEL CAESAR J
EVP, Chief Legal Officer
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-04-13$13.05/sh−50,000$652,500→ 0 total
    Exercise: $16.95Exp: 2018-04-17→ Common Stock (50,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-04-13$21.22/sh−65,000$1,379,300→ 0 total
    Exercise: $8.78Exp: 2018-12-22→ Common Stock (65,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-04-13$26.79/sh−1,059$28,371→ 0 total
    Exercise: $3.21Exp: 2013-05-07→ Common Stock (1,059 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-04-13$18.07/sh−75,000$1,355,250→ 0 total
    Exercise: $11.93Exp: 2015-10-17→ Common Stock (75,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-04-13$17.63/sh−90,000$1,586,700→ 0 total
    Exercise: $12.37Exp: 2016-05-12→ Common Stock (90,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-04-13$19.27/sh−4,545$87,582→ 0 total
    Exercise: $10.73Exp: 2016-06-22→ Common Stock (4,545 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-04-13$15.01/sh−45,000$675,450→ 0 total
    Exercise: $14.99Exp: 2017-06-14→ Common Stock (45,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-04-13$15.77/sh−12,000$189,240→ 0 total
    Exercise: $14.23Exp: 2015-09-23→ Common Stock (12,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-04-13$11.61/sh−75,000$870,750→ 0 total
    Exercise: $18.39Exp: 2019-12-21→ Common Stock (75,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-04-13$13.46/sh−75,000$1,009,500→ 0 total
    Exercise: $16.54Exp: 2020-12-22→ Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]This option, whether fully vested or not, was terminated upon the completion of the merger of Magnolia Acquisition Corp. with and into Clinical Data, Inc. pursuant to the Agreement and Plan of Merger dated February 22, 2011, as amended on April 4, 2011. Pursuant to the Agreement and Plan of Merger, the option was converted into the right to receive $30.00 per share (minus the exercise price of the option) in cash plus contingent consideration of up to $6.00 per share that may be paid upon achievement of certain commercial milestones, subject to any applicable tax withholdings.

Documents

1 file

Issuer

CLINICAL DATA INC

CIK 0000716646

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000716646

Filing Metadata

Form type
4
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 10:54 AM ET
Size
25.5 KB
View on SEC.gov